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Abstract
Schistosomiasis is a parasitic zoonosis caused by small trematode worms called schistosomes, amongst which Schistosoma
japonicum (S. japonicum) is endemic in Asia. In order to understand the schistosome-induced changes in the host
metabolism so as to facilitate early diagnosis of schistosomiasis, we systematically investigated the dynamic metabolic
responses of mice biofluids and liver tissues to S. japonicum infection for five weeks using
1H NMR spectroscopy in
conjunction with multivariate data analysis. We were able to detect schistosomiasis at the third week post-infection, which
was one week earlier than ‘‘gold standard’’ methods. We found that S. japonicum infection caused significant elevation of
urinary 3-ureidopropionate, a uracil catabolic product, and disturbance of lipid metabolism, stimulation of glycolysis,
depression of tricarboxylic acid cycle and disruption of gut microbiota regulations. We further found that the changes of 3-
ureidopropionate and overall metabolic changes in both urinary and plasma samples were closely correlated with the time-
course of disease progression. Furthermore, such changes together with liver tissue metabonome were clearly associated
with the worm-burdens. These findings provided more insightful understandings of host biological responses to the
infection and demonstrated that metabonomic analysis is potentially useful for early detection of schistosomiasis and
comprehension of the mechanistic aspects of disease progression.
Citation: Wu J, Xu W, Ming Z, Dong H, Tang H, et al. (2010) Metabolic Changes Reveal the Development of Schistosomiasis in Mice. PLoS Negl Trop Dis 4(8): e807.
doi:10.1371/journal.pntd.0000807
Editor: Paul J. Brindley, George Washington University Medical Center, United States of America
Received May 3, 2010; Accepted August 3, 2010; Published August 31, 2010
Copyright:  2010 Wu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors acknowledge financial support from the Chinese Academy of Sciences (the Knowledge Innovation Program, KJCX2-YW-W11) and the
National Natural Science Foundation of China (20825520, 20921004). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: huiru.tang@wipm.ac.cn (HT); yulan.wang@wipm.ac.cn (YW)
Introduction
Schistosomiasis is a chronic parasitic disease caused by infection
with schistosomes. As one of the most infectious species, Schistosoma
japonicum is mainly endemic in Asia with over 1 million infected
individuals and about 46 million people at risk in China, the
Philippines and Indonesia [1–3]. During schistosomiasis progres-
sion, schistosomes mature to adults in the hepatic circulation and
then in pairs migrate to inhabit in the mesenteric veins, where they
mate and lay a large number of eggs in the vessels of the intestinal
wall. Consequently, schistosomiasis causes diarrhea, fatigue,
anemia at the early stage of infection, and portal vein hypertension
syndrome, ascites and liver fibrosis at the later stages [1].
Currently, schistosomiasis is diagnosed using the Kato-Katz
technique by detecting eggs in feces under microscope [4], or
with immunological approaches by detecting soluble antigens
secreted from the hatching-eggs via the antigen-antibody reaction
[5–6]. However, such methods are not suitable for early diagnosis
and the adverse effects associated with the deposition of
schistosome eggs would have already occurred when diagnosis
were made. Therefore, development of early diagnostic methods is
in urgent need so as to treat patients timely to prevent clinical
complications. Understanding the dynamic responses of the hosts
with schistosomiasis in the systems level is important to provide
insights into the mechanisms underlying disease progression and
thus could be potentially useful for early diagnosis of schistosomi-
asis.
Previous work has examined the schistosomiasis-caused alter-
ations in the transcription and protein levels. Reductions in
biologically active albumin mRNA and increased type I
procollagen mRNA were observed in the liver of S. mansoni
infected mice 6 weeks post-infection [7]. However, no such
changes were noted at the earlier stages of infection [7]. The
expressions of proteins associated with structural components
(procollagen VI, keratin and actin), the stress responses (heat shock
proteins, chaperones) were significantly promoted [8], which may
be relevant to the infection-caused liver fibrosis and schistosomes’
uptake of host proteins onto their tegument during development
[9]. Furthermore, S. mansoni infection caused significant increases
in the activities of pyruvate kinase and phosphofructokinase but
marked reductions in the activities of citrate synthase, glycogen
phosphorylase, glucose-6-phosphate dehydrogenase, carbamoyl
phosphate synthetase and ornithine carbamoyltrasferase [10–11].
Such observations were consistent with recent proteomic results
that S. mansoni infection (for 8 weeks) caused remarkable decreases
in the expression of host liver enzymes associated with the Krebs
cycle, fatty acid cycle, urea cycle, amino acid metabolism and
catabolism, amongst which the expression of malic enzyme was
decreased 15-folds by infection [8]. However, it is not clear thus
far whether such systems responses are generic for infections by
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at the early stage of infections.
The analysis of host metabolite composition (i.e., metabonome)
is a well suited approach to understand the holistic metabolic
responses to infections since metabonomics is a branch of science
concerned with the metabolite composition of biological systems
and its dynamic responses to both endogenous and exogenous
stimuli [12–14]. As a powerful holistic analytical approach,
metabonomics has already been widely applied in studies of
disease pathogenesis [15–17], drug toxicity [18–19] and in the
environmental [20–21] and nutritional sciences [22–23]. This
approach has also been successfully applied in parasitological
studies with comprehensive characterizations of the host metabolic
responses to infections by several parasites, such as Trypanosoma
brucei brucei [24], Plasmodium berghei [25] and Echinostoma caproni [26–
27]. The results also showed that schistosomal infections led to
suppression of the hosts’ Krebs cycles, disruption of amino acid
metabolism, liver injuries and disturbances of the gut microbiota
[28–29]. A recent study revealed that S. mansoni infection resulted
in significant metabolic alterations in a range of mouse tissues [30].
Metabolic alterations were also comprehensively studied for
hamster models co-infected with S. japonicum and Necator americanus
[31]. However, the previous investigations were all based on a
well-established late-stage schistosomal infection model. The
dynamic metabolic responses associated with progression of
infection remained to be elucidated.
In this work, we systematically investigated the time-course
metabonomic changes in urine and blood plasma of the S.
japonicum infected mice over 5 weeks and liver tissues at the fifth
week post-infection using
1H NMR spectroscopy and multivariate
data analysis. The main objectives are to define the host
metabonomic responses to infection at the early stages and their
dynamic changes during the disease progression, which are of
potential importance for early diagnosis and prognostic under-
standings of schistosomiasis.
Materials and Methods
Parasite, host and infection
A total of 60 female pathogen free BALB/c mice, about 8 weeks
old weighing 2062 g, were purchased from the animal laboratory
center of Wuhan university (China), and housed in groups of 5 in
plastic cages under environmentally-controlled conditions (tem-
perature: 18,22uC; humidity: 40,70%; light-dark cycle: 12–
12 h). Mice had free access to rodent food and water. After 3
weeks of acclimatization, half of the mice (n=30) were infected
with 8062 S. japonicum cercariae, each via shaved abdominal skin.
The cercariae were obtained from infected O. hupensis (Anhui) after
exposure to artificial light. The rest of the mice served as controls.
Ethics statement
All experimental procedures were performed according to the
National Guidelines for Experimental Animal Welfare (MOST of
People’s Republic of China, 2006) and were approved by the
Animal Welfare Committee of Wuhan University (Permission No.
SYXK (E) 2008–0013).
Sample collection, S. japonicum worm burden and
histology
Plasma and urine samples were collected one day before
infection and after infection for five weeks on a weekly basis.
Sample collection was carried out between 08:30–11:30 in order
to avoid potential metabolic variations due to diurnal cycle. Blood
samples (70,80 ml) were collected from the orbital venous plexus
and transferred to Eppendorf tubes containing 5 ml sodium
heparin, followed by centrifugation at 3000 g for 10 mins. The
supernatant (,30 ml) was transferred into 0.5 ml Eppendorf tubes,
immediately immersed in liquid nitrogen, and stored at 280uC.
Urine samples (50,400 ml) were collected in empty plastic boxes
by gently massaging the abdomen of mice and transferred into
Eppendorf tubes, stored at 280uC.
Half of the mice (15 control and 15 infected mice) were
sacrificed at 5 weeks post-infection by cervical dislocation and the
remaining mice were kept for a separate experiment. Plasma at
sacrifice was divided into two portions with one portion kept for
NMR analysis and the other for clinical biochemistry analysis. The
adult schistosomes were isolated by perfusion via the heart with
saline solution containing heparin. The worms in the portal vein
and the mesenteric veins were pushed out gently with a dissecting
needle. All harvested S. japonicum worms were sexed and counted
for worm burden assessments. The middle lobe of liver was excised
and immediately snap-frozen in liquid nitrogen and stored at
280uC for
1H High Resolution Magic Angel Spinning (HR MAS)
NMR analysis. Another small portion of the liver was stored in
10% formalin solution for histological assessments where tissue
samples were sectioned into 5 mm slices and stained with H&E and
examined under a light microscope (BRX-51, Leica, Germany).
1H NMR spectroscopy
Urine samples were prepared by adding D2O into urine
(50,400 ml) to make a final volume of 500 ml. Then the liquid was
mixed with 50 mlN a
+/K
+ buffer (K2HPO4/NaH2PO4 in D2O,
1.5M, pD 7.4) [32], containing 0.01% sodium 3-trimethylsilyl
(2,2,3,3-
2H4) propionate (TSP) for chemical shift reference. After
being vortexed and centrifuged at 10000 g, 4uC, supernatant of
500 ml was transferred into 5 mm NMR tubes. The urinary
1H
NMR spectra were acquired at 298 K from a Bruker AVIII 600
MHz NMR spectrometer (Bruker Biospin, Germany) equipped
with a cryogenic probe, operating at 600.13 MHz proton
frequency. The plasma samples were prepared by mixing 30 ml
Author Summary
Schistosomiasis is an infectious disease resulting from the
infection of parasitic trematode worms called schisto-
somes. About 600 million people are currently exposed to
schistosomiasis and 200 million people are infected in
about 76 countries. Current diagnostic methods are unable
to detect schistosomiasis at its early stages and thus are
incapable of preventing disease causing further complica-
tions. In order to understand the effects of schistosome
infection on hosts’ biochemistry associated with disease
progression in a holistic fashion and detect the infection at
the early stage, we systematically investigated the
metabolite composition (metabonome) changes in mice
biofluids and liver tissues induced by Schistosoma japoni-
cum using NMR spectroscopy. We detected infection-
induced mice metabonomic alterations at three weeks
post-infection, a week earlier than traditional methods. We
found that the infection-caused elevation of urinary 3-
ureidopropionate was not only associated with disease
progression but also worm burden. We further found that
overall metabonomic changes were also closely associated
with disease progression, and our methods were capable
of distinguishing different levels of worm burden at week
five post-infection. Our findings provided further under-
standings in host responses to the infection and demon-
strated metabonomics as a potentially useful tool for early
diagnosis of S. japonicum infections.
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30 mM phosphate buffer (pD 7.4). The mixed liquid was
transferred into 1.7 mm micro NMR tubes.
1H NMR spectra of
plasma were recorded at 298 K on a Bruker AVP 500 NMR
spectrometer, operating at 500.13 MHz proton frequency with a
broad band inverse detection probe. Liver samples (about
15,20 mg) were rinsed with 0.9% saline (D2O) and placed in a
4 mm zirconia rotor with a spin rate of 2200 Hz. HR MAS
1H
NMR spectra of liver tissues were acquired at 283 K on a Varian
INOVA-600 spectrometer equipped with a Varian nanoprobe,
operating at 599.81 MHz proton frequency.
A standard water suppressed one dimensional NMR experiment
using sequence [recycle delay 290u2t1290u2tm290u-acquisition]
was employed for urine [28]. A spin relaxation edited-water
saturated
1H NMR experiment using Carr-Purcell-Meiboom-Gill
(CPMG) pulse sequence was performed for both plasma and liver
tissues. A total spin-spin relaxation delay of 70 ms and 400 ms was
used for plasma and liver tissues respectively. The 90u pulse length
was adjusted to 10 ms. A total of 256 scans were accumulated into
32 k data points, with a spectral width of 20 ppm for plasma and
liver samples, and 32 scans were recorded for urine samples. For
spectral assignment purposes, two dimensional (2D) NMR spectra
(
1H-
1H COSY and TOCSY,
1H-
13C HSQC and HMBC) were
acquired on selected samples utilizing standard acquisition
parameters [18,33–34].
Data reduction and multivariate pattern recognition
analysis
1H NMR spectra were corrected for phase and baseline
distortion, and referenced manually using TOPSPIN package
(V2.0, Bruker Biospin, Germany). Spectra were segmented into
integral regions of 0.002 ppm for urine and 0.004 ppm for plasma
and liver using the AMIX package (V3.8, Bruker Biospin,
Germany). The distorted water regions were removed to eliminate
the effects of water suppression prior to normalization of the data
to the total sum intensity of the spectrum.
SIMCA-P
+ software package (V.12, Umetrics, Sweden) was
employed for multivariate data analysis. Principal component
analysis (PCA) was performed by using a mean-centered NMR
data to identify general trends and outliers. A supervised
multivariate data analysis tool, orthogonal-projection to latent
structure discriminant analysis (O-PLS-DA) [35–36], was em-
ployed with the Pareto scaling method [37]. All models were cross
validated using a 7-fold method [38]. In supervised pattern
recognition method, validation of model is crucial for interpreta-
tion of data and hence all models here have been rigorously
evaluated with permutation tests (permutation numbers=200)
[39–40]. In order to facilitate interpretation of the results, back-
transformation of the loadings was performed as described
previously [41] and plotted with color-coded coefficients for each
variable using in-house developed MATLAB scripts.
Clinical biochemistry analysis
The clinical biochemistry of serum was measured using an
automatic biochemistry analyzer. Independent t-tests were con-
ducted using SPSS 12.0 software and expressed as mean 6 SD.
Results
Parasitemia, histology and clinical chemistry
On average, 42 live S. japonicum worms were found (with
standard deviation of 12) in the infected mice but with no
significant bodyweight differences between the control and
infected animals. Histopathological examinations of liver from
the infected mice (5 weeks post-infection) showed grayish irregular
nodules and marked schistosomal hepatic lesions (Fig. S1). Clinical
serum chemistry results (Table 1) indicated that S. japonicum
infection led to significant increases in the activities of alanine
aminotransferase (ALT) (ca. 5 folds), aspartate aminotransferase
(AST) (.1 fold), and their ratio (ALT/AST). Infection also caused
significant increases in the levels of globulin and decreases in the
levels of albumin, alkaline phosphatase, triglyceride and the
albumin-to-globulin ratio.
1H NMR spectra of plasma, urine and liver tissues
1H NMR spectra of mice plasma, liver tissues (Fig. 1) and urine
(Fig. 2) samples contained rich metabolite information with all
NMR resonances assigned according to literature data [34,42–43]
and further confirmed with a catalogue of 2D NMR spectra.
Glucose, lipoproteins, citrate, creatine and a range of amino acids
were detected in the plasma and intact liver tissues from both
control and infected BALB/c mice (Fig. 1). Visual inspection of the
plasma spectra revealed that the infected samples (Fig. 1B)
contained higher levels of N-acetyl-glycoproteins together with
lower levels of lipids, citrate and alanine than controls (Fig. 1A).
The metabolic profiles of liver tissues of the infected mice (Fig. 1D)
had lower levels of glucose and glycogen accompanied with higher
levels of choline metabolites, such as phosphorylcholine (PC) and
glyceryl phosphorylcholine (GPC), and alanine than controls
(Fig. 1C).
1H NMR spectra of urine from infected mice (Fig. 2B) showed
obvious elevated levels of 2-keto-isocaproate, 2-keto-3-methyl-
valerate, 2-keto-isovalerate, pyruvate, 4-cresol glucuronide, 3-
ureidopropionate (3-UP), dimethylamine (DMA), trimethylamine
(TMA), phenylacetylglycine (PAG) and alleviated levels of adipate,
taurine and hippurate compared with the controls (Fig. 2A). To
further obtain the detailed metabonomic differences, we employed
multivariate data analysis approaches.
Table 1. Clinical chemistry data for the control and
S. japonicum infected mice at week 5 post-infection
{.
5 weeks post-infection
control Infection Significance
ALT (IU/L) 61.0620.4 358.76199.6*** q
AST (IU/L) 166.3654.7 381.46152.1*** q
ALT/AST 0.460.10 0.960.3*** q
ALB (IU/L) 41.661.42 38.064.0** Q
Globulin (IU/L) 17.163.0 22.163.3*** q
A/G 2.560.3 1.860.4*** Q
TP (IU/L) 58.763.7 60.163.0 -
ALP (IU/L) 108.9616.2 72.7630.0*** Q
Glucose (mmol/
L)
6.460.8 5.761.1 -
Chol (mmol/L) 2.660.4 2.460.2 -
TG (mmol/L) 1.260.4 0.860.3*** Q
{Values are expressed as means 6 S.D. Statistics: (**)p,0.01, (***)p,0.001
(n=15 for each group, except for the TG and ALP of the non-infected group
where n=14 due to insufficient sample volume). Keys: ALT (alanine
aminotransferase), AST (aspartate aminotransferase), ALP (alkaline
phosphatase), TP (total protein), ALB (Albumin), Chol (cholesterol), TG
(Triglyceride).
doi:10.1371/journal.pntd.0000807.t001
Metabolic Changes in Schistosomiasis Development
www.plosntds.org 3 August 2010 | Volume 4 | Issue 8 | e807Metabolic variations associated with S. japonicum
infection
Initial PCA of the mean-centered NMR spectral data from
plasma of the S. japonicum infected mice and corresponding
controls showed that one control sample containing markedly low
levels of lipoproteins appeared to cluster closely with the infected
group (data not shown). One sample from the infected group was
associated with the control group at all time points probably
because it had significantly low worm burden with worm count of
only 18. We therefore removed these two animals from subsequent
data analysis in order to avoid possible confusions.
PCA trajectory (Fig. S2) demonstrated that the metabolic
profiles of both mice plasma and urine samples had an association
with the time course of S. japonicum infection and disease
progression. The metabolic profiles obtained from the infected
mice deviated from the corresponding controls from the third
week post-infection onwards and such separations became more
obvious as disease progression. In order to identify the metabolites
associated with such separations, we further compared the
metabolic profiles obtained from the infected mice and corre-
sponding controls for all matched time points, including the pre-
infection day, week 1, 2, 3, 4 and 5 post-infection, using O-PLS-
DA strategy. The same strategy was utilized to analyze spectral
data of liver tissues obtained from mice at week 5 post-infection.
These O-PLS-DA models were validated using a 7-fold cross-
validation strategy and rigorous permutation tests [39–40]. Judged
from the values of R
2X (goodness of fit) and Q
2 (robustness of the
models) (Tables 2 and 3) and permutation tests (Fig. S3; Fig S4),
valid O-PLS-DA models were obtained for plasma and urine
samples collected at week 3, 4 and 5 post-infection (Fig. 3A–C and
Fig. 4A–C), and liver tissues at week 5 post-infection (Fig. 5). As
noted, plasma (Fig. 3C) and urine (Fig. 4C) samples collected at
week 5 post-infection were further separated into two subgroups.
These subgroups were associated with the numbers of worm
burden, including a group with a light-infection (average worms:
36.3611.1) and the other a heavy-infection (average worms:
5168.4, p=0.02). Additional O-PLS-DA comparisons between
the control group and the lightly-infected, the control and the
heavily-infected groups were performed to assess the variation of
metabolites at different infection levels in plasma and urine (Fig. 3
D, E and Fig. 4 D, E).
Color-coded coefficient plots (Fig. 3a–e and Fig. 4a–e) from O-
PLS-DA revealed detailed mice metabolic changes induced by S.
japonicum infection with coefficients summarized in Tables 2 and 3.
The discrimination significance at the level of p,0.05 was
determined for specific metabolites according to the test for the
significance based on the Pearson product-moment correlation
coefficients, where the absolute coefficient cutoff values (|r|) were
0.361 for models following 3, 4 and 5 weeks infection (Fig. 3a–c
and 4a–c) whereas such values were 0.514 and 0.497 for light
(Fig. 3d and 4d) and heavy infection (Fig. 3e and 4e) at week 5
post-infection, respectively. The upwards and downwards peaks
respectively denote the elevated and alleviated metabolites in the
infected mice with hot colored (e.g. red) metabolites contributing
more significantly to the class discrimination than cold colored
ones. Blood plasma samples showed significant elevation of glucose
and a range of amino acids together with depletion of lipoproteins
and keto-bodies, including D-3-hydroxybutyrate and acetone after
infection for 3 and 4 weeks (Fig. 3a–b). Compared to the controls,
the metabolic changes of plasma obtained from the lightly infected
mice (Fig. 3d) at week 5 post-infection were similar to those
obtained from the mice at week 4 post-infection (Fig. 3c) whereas
additional metabolite changes were observed for the heavily
infected mice at week 5 post-infection (Fig. 3e). Such changes
Figure 1.
1H NMR spectra of plasma and liver tissue from
control and S. japonicum infected mice. Typical 500 MHz
1H (CPMG)
NMR spectra of plasma obtained from a non-infected BALB/c mouse (A)
and a mouse infected with S. japonicum for 5 weeks (B). Typical 600
MHz
1H HRMAS (CPMG) NMR spectra of intact liver tissue obtained from
a non-infected mouse (C) and a mouse infected with S japonicum for 5
weeks (D). Keys: 1, valine; 2, leucine; 3, isoleucine; 4, D-3-hydroxybu-
tyrate; 5, lactate; 6, alanine; 7, lysine; 8, acetate; 9, N-acetyl-glycoprotein;
10, methionine; 11, acetone; 12, acetoacetate; 13, glutamate; 14,
glutamine; 15, citrate; 16, pyruvate; 17, creatine; 18, choline; 19,
phosphorylcholine; 20, glyceryl phosphorylcholine; 21a, a-glucose; 21b,
b-glucose; 22, lipids; 23, aspartate; 24, trimethylamine-N-oxide; 25,
taurine; 26, glycine; 27, glycogen; 28; scyllo-inositol; U1, unknown1.
doi:10.1371/journal.pntd.0000807.g001
Figure 2.
1H NMR spectra of urine samples from control and S.
japonicum infected mice. Typical 600 MHz
1H NMR spectra of urine
samples obtained from a non-infected BALB/c mouse (A) and a mouse
infected with S. japonicum for 5 week (B). The spectral region, d 6.7–8.5,
was vertically expanded 4 times compared with the aliphatic region (d
0.7–4.2). Keys: 5, lactate; 8, acetate; 9, N-acetyl-glycoproteins; 15, citrate;
16, pyruvate; 17, creatine; 24, trimethylamine-N-oxide; 25, taurine; 29, 2-
keto-isocaproate; 30, 2-keto-3-methyl-valerate; 31, 2-keto-isovalerate;
32, 2-hydroxyisobutyrate; 33, 2-(4-hydroxyphenyl) propanoic acid; 34,
adipate; 35, 4-cresol glucuronide; 36, 3-ureidopropionate; 37, succinate;
38, 2-oxo-glutarate; 39. dimethylamine; 40, trimethylamine; 41, creat-
inine; 42, malonate; 43, phenylacetylglycine; 44, guanidinoacetate; 45,
hippurate; 46, indoxylsulfate; 47, formate; U2,unknown2; U3, unknown3.
doi:10.1371/journal.pntd.0000807.g002
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levels of glucose, citrate (i.e., Krebs cycle intermediate) and choline
metabolites (Fig. 3e) such as PC and GPC.
Compared with controls, the infected mice showed obvious
urinary metabolic changes at week 3 post-infection with significant
elevation of 2-keto-3-methyl-valerate, 2-keto-isovalerate, 3-UP and
some gut-microbiota related metabolites, including TMA, tri-
methylamine-N-oxide (TMAO) and PAG together with alleviation
of adipate and Krebs cycle intermediates (such as succinate, 2-
oxoglutarate and citrate). As the disease progressing, elevated
levels of 4-cresol glucuronide, pyruvate, dimethylamine, malonate,
glycine, indoxysulfate, and decreased levels of a-hydroxyisobuty-
rate, acetate, taurine and hippurate were observed in the urine of
infected mice. The urinary metabolic profiles obtained from the
lightly infected mice at week 5 post-infection were characterized
by the increased pyruvate, glycine, 3-UP and microbiota related
metabolites, such as PAG, 4-cresol glucuronide and TMA (Fig. 4d).
For the heavily infected group, additional elevation of 2-keto-3-
methyl-valerate, 2-keto-isovalerate and creatine together with
alleviation of hippurate, 2-(4-hydroxyphenyl) propanoic acid and
citrate were noted (Fig. 4e).
The cross-validated O-PLS-DA was further conducted for the
metabolic profiles of liver tissue obtained at week 5 post-infection.
The color-coded coefficient plot (Fig. 5) indicated that compared
to controls, the infected mice showed higher levels of hepatic
lactate, choline, PC, GPC, TMAO, taurine, creatine and a range
of amino acids together with lower levels of glucose and glycogen
(Table 2).
Correlation of
1H NMR data with worm burden
Projection to latent structures (PLS) models were constructed
using Pareto-scaled NMR data of plasma, liver and urine obtained
at week 5 post-infection as corresponding X matrices and worm
burden as Y matrix (Fig. 6). Significant correlations were found
Table 2. Metabolites with significant contributions to the discrimination between non-infected and S. japonicum-infected mice
derived from plasma and liver.
Metabolites (key)
Chemical
shift (ppm)
Plasma
R
2X=0.53
Q
2=0.24
Plasma
R
2X=0.53
Q
2=0.64
Plasma
R
2X=0.48
Q
2=0.66
Plasma
R
2X=0.52
Q
2=0.60
Plasma
R
2X=0.71
Q
2=0.91
Liver
R
2X=0.63
Q
2=0.73
inf vs con inf vs con inf vs con light vs con heavy vs con inf vs con
3weeks p.i. 4weeks p.i. 5weeks p.i. 5weeks p.i. 5weeks p.i. 5weeks p.i.
Acetate 1.91 20.54{
Acetone 2.23 20.55 20.74 20.40 20.64
Alanine 1.48 20.47 20.60 +0.87
Aspartate 2.68, 2.82 +0.93
Choline 3.19 +0.60 +0.81
Citrate 2.52, 2.67 20.59 20.66
Creatine 3.92 +0.69 +0.75 +0.71 +0.73 +0.74
D-3-Hydroxybutyrate 1.18 20.42 20.53
Dihydrothymine 1.07 +0.37 +0.67 +0.75
Glycine 3.55 +0.55 +0.75
Glycogen 5.41 20.70
Glucose 3.24 +0.83 +0.92 20.47 +0.53 20.78 20.61
Glutamate 2.09 +0.66 +0.87 +0.87 +0.85 +0.95
Glutamine 2.45 +0.86 +0.73 +0.72 +0.81 +0.89
GPC + PC 3.21 20.60 20.72 +0.95
Lactate 1.33 +0.68
Lysine 1.70 +0.92 +0.75 +0.96 +0.87
Lipid fraction 0.89, 1.25, 1,57, 2.02,
2.23, 2.72, 5.30
20.54 20.80 20.83 20.80 20.77
N-acetyl-glycoprotein 2.07 +0.92 +0.92
Pyruvate 2.37 20.37 20.52
Scyllo-inositol 3.35 +0.38
Taurine 3.42 +0.92
TMAO 3.27 +0.92
Valine 1.04 +0.48 +0.58 +0.38 +0.76
Unknown1 4.12 +0.59 +0.74 +0.96 +0.90 +0.98
{Numbers are correlation coefficients obtained from O-PLS-DA.
+ indicates an increase in the concentration of metabolites in the infected group.
2 indicates a decrease in the concentration of metabolites in the infected group.
p.i. stands for post-infection.
doi:10.1371/journal.pntd.0000807.t002
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(Fig. 6A), liver tissues (Fig. 6B) and urine samples (Fig. 6C). In
plasma, reduced levels of glucose, pyruvate and increased levels of
lysine and N-acetyl glycoprotein were closely associated with the
worm burden (Fig. 6A) whilst, in the liver, reduced levels of
glucose, glycogen and increased level of glutamate, glutamine were
related to worm burden (Fig. 6B). In urine samples, the worm
burden was associated with the elevated levels of PAG, 3-UP,
creatine, 4-cresol glucuronide, TMAO and DMA together with
alleviated levels of hippurate, 2-(4-hydroxyphenyl) propanoic acid
and adipate (Fig. 6C).
Fig. 7 shows the alterations of relative concentrations of typical
metabolites as a function of infection duration and worm burden. It
is apparent that infection causes steady increases in the concentra-
tions of 3-UP, PAG and pyruvate together with decrease in the
concentration of citrate. The elevation of 3-UP starts from week 3
post-infection and is positively correlated with infection duration
and worm burden. Marked changes occurred at the fourth week
post-infection for 3-UP, gut microbiota related metabolites (PAG,
hippurate, DMA and TMA), pyruvate and citrate.
Discussion
Above results indicated that metabolic changes in plasma, urine
and liver tissues were all closely associated with the presence and
severity of S. japonicum infection as indicated by the levels of worm
burden. This work also comprehensively described the time-course
metabolic responses of mice to schistosome infection with
Table 3. Urinary metabolites with significant contributions to the discrimination between non-infected and S. japonicum-infected
mice.
Metabolites (key) Chemical shift (ppm) R
2X=0.31 R
2X=0.36 R
2X=0.42 R
2X=0.30 R
2X=0.47
Q
2=0.53 Q
2=0.46 Q
2=0.56 Q
2=0.60 Q
2=0.89
inf vs con inf vs con inf vs con light vs con heavy vs con
3weeks p.i. 4weeks p.i. 5weeks p.i. 5weeks p.i. 5weeks p.i.
2-(4-hydroxyphenyl)
propanoic acid
1.37, 3.57, 6.89, 7.20 20.83 20.9
2-Oxoglutarate 2.45, 3.01 20.63{ 20.39
2-hydroxyisobutyrate 1.36 20.6 20.77 20.66
2-keto-3-methyl-valerate 1.10 +0.47 +0.49 +0.45 +0.52
2-keto-isocaproate 0.94, 2.1, 2.61 +0.42
2-keto-isovalerate 1.13 +0.46 +0.62 +0.67 +0.72
3-Ureidopropionate 2.38 +0.46 +0.55 +0.86 +0.83 +0.93
4-cresol glucuronide 2.29, 7.06, 7.23 +0.60 +0.72 +0.8 +0.64
Acetate 1.92 20.48
Adipate 1.57, 2.20 20.81 20.68 20.91 20.75 20.94
Citrate 2.56, 2.72 20.68 20.64 20.8
Creatine 3.03,3.93 +0.4 20.45 +0.66 +0.84
Dimethylamine 2.71 +0.61 +0.79 +0.58 +0.82
Fumarate 6.53 20.51 20.72 20.62
Glycine 3.55 +0.5 +0.56 +0.52
Hippurate 7.55, 7.84 20.73 20.82
Indoxylsulfate 7.21, 7.27 +0.64 +0.8 +0.6
Lactate 1.33 +0.51
Malonate 3.12 +0.49 +0.55
N-acetyl-glycoprotein 2.02 +0.7 +0.52 +0.76 +0.65
PAG 3.68 3.75,7.37, 7.43 +0.67 +0.54 +0.76 +0.9 +0.77
Pyruvate 2.34 +0.7 +0.77 +0.81 +0.72
Succinate 2.41 20.41 20.52 20.39
Taurine 3.27, 3.43 +0.48 20.46 20.51
Trimethylamine 2.88 +0.5 +0.38 +0.73 +0.85 +0.83
TMAO 3.27 +0.53 +0.48 +0.59
Unknown 2 1.78 +0.55 +0.69 +0.78
Unknown 3 1.08 +0.65 +0.76
{Numbers are correlation coefficients obtained from O-PLS-DA.
+ indicates an increase in the concentration of metabolites in the infected group.
2 indicates a decrease in the concentration of metabolites in the infected group.
p.i. stands for post-infection.
doi:10.1371/journal.pntd.0000807.t003
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infection.
Metabolic response of infection at early stage
Previous investigations of metabolic response of schistosomal
infections have been focused on the end point of one schistosome
life cycle [28–30] when eggs have been produced. The metabolic
responses of the same host to schistosome infection over time,
starting from an early stage of infection have not been previously
studied. Our investigation clearly showed that the schistosomal
infection-induced metabolic changes were detectable from the
third week post-infection in both plasma and urine samples
(Fig. 3A and 4A). Such detection of infection is achieved one week
earlier than the current ‘‘gold standard’’ method. S. japonicum
worms reach maturity and begin to lay eggs around 4 weeks post-
infection [44–45]. In the current study, the variations in metabolic
profiles induced by the infection occurred before sexual matura-
tion of S. japonicum worms in the mammalian host and thus prior to
liver injuries by deposition of schistosomal eggs. Infection severity
was also distinguished based on the metabolic profiles of both
urine and plasma (Fig. 3C and 4C). Furthermore, metabolic
profiles of plasma, urine and liver tissues are highly correlated with
the intensities of worm burden (Fig. 6 and Fig. 7). These findings
imply that metabonomic investigations of blood plasma and urine
are potentially useful in the development of an early diagnostic
tool for S. japonicum infection and assessment of infection severity.
S. japonicum infection induced dynamic metabonomic
changes
Liver injury is one of the most important manifestations of S.
japonicum infection in humans. Our clinical chemistry data (Table 1)
and histological results (Fig.S1) confirmed the occurrence of liver
injuries at week 5 post-infection, being consistent with a previous
human investigation [46]. One of the metabolic consequences of
liver injury is the disturbance of amino acid metabolism, resulting
in accumulation of amino acids in the liver and their depletion in
plasma. In fact, such disturbed amino acid metabolism was
previously noted with high levels of alanine, asparagine, creatine,
glutamine and glycine in the S. mansoni infected mice liver [30].
These changes are also broadly similar to the increased
concentrations of glutamine and glutamate relative to the lipids
resulting from liver injuries caused by chronic hepatitis [47]. Our
Figure 3. O-PLS-DA comparison between NMR spectra of plasma from the S. japonicum infected mice and corresponding controls.
Cross-validated scores (left) and coefficient-coded loadings (right) plots for the comparative O-PLS-DA of plasma data for non-infected and S.
japonicum-infected mice at different time points. Non-infected (black squares) vs infected (red dots) mice 3 weeks post-infection (A), 4 weeks post-
infection (B) and 5 weeks post-infection (C). Non-infected vs lightly infected mice (green) (D) and heavily infected mice (blue) (E) at week 5 post-
infection. The colored scale is for coefficients being indicative to the significance of metabolite contributions to the differentiation between classes.
Keys: 1, valine; 2, leucine; 3, isoleucine; 4, D-3-hydroxybutyrate; 5, lactate; 6, alanine; 7, lysine; 8, acetate; 9, N-acetyl-glycoprotein; 10, methionine; 11,
acetone; 12, acetoacetate; 13, glutamate; 14, glutamine; 15, citrate; 16, pyruvate; 17, creatine; 18, choline; 19, phosphorylcholine; 20, glyceryl
phosphorylcholine; 21a, a-glucose; 21b, b-glucose; 22, lipid; 23, aspartate; 24, trimethylamine-N-oxide; 25, taurine; 26, glycine; 27, glycogen; 28; scyllo-
inositol; U1, unknown1.
doi:10.1371/journal.pntd.0000807.g003
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indicating that there might be some commonality for the
metabolic responses to liver injuries caused by different schisto-
some species.
The accumulation of taurine observed here in the liver of
schistosomal infected mice is probably due to the liver injury
caused deficiency in the formation of taurine-conjugated bile acids
and thus subsequent malabsorption that has been reported in
human infected with schistosomes [1]. Since taurine is also a cell
membrane stabilizer to maintain osmosis [48], its over-represen-
tation in liver may also reflect the liver cell membrane
abnormalities following infection. Such view is further supported
by the infection-induced accumulation of the cell membrane
components (GPC and PC) in the host liver observed in current S.
japonicum and previous S. mansoni infections [30].
Another important consequence of liver injury is stimulated
glycolysis, which is manifested by marked reduction in levels of
plasma glucose, liver glucose and glycogen, and the accumulation
Figure 4. O-PLS-DA comparison between NMR spectra of urine from S. japonicum infected mice and corresponding controls. Cross-
validated scores (left) and coefficient-coded loadings (right) plots for the comparative O-PLS-DA of urine data for non-infected and S. japonicum-
infected mice at different time points. Non-infected (black boxes) vs infected (red dots) mice 3 weeks post-infection (A), at 4 weeks post-infection (B)
and 5 weeks post-infection (C). Non-infected vs lightly infected mice (green) (D) and heavily infected mice (blue) (E) at week 5 post-infection. Keys: 29,
2-keto-isocaproate; 30, 2-keto-3-methyl-valerate; 31, 2-keto-isovalerate; 32, 2-hydroxyisobutyrate; 33, 2-(4-hydroxyphenyl) propanoic acid; 34, adipate;
35, 4-cresol glucuronide; 36, 3-ureidopropionate; 37, succinate; 38, 2-oxo-glutarate; 39. dimethylamine; 40, trimethylamine; 41, creatinine; 42,
malonate; 43, phenylacetylglycine; 44, guanidinoacetate; 45, hippurate; 46, indoxylsulfate; 47, formate; U2; unknown2; U3, unknown3.
doi:10.1371/journal.pntd.0000807.g004
Figure 5. O-PLS-DA comparison between NMR spectra of liver tissue from the S. japonicum infected mice and controls. Cross-validated
scores (left) and coefficient-coded loadings (right) plots for the comparative O-PLS-DA of the CPMG filtered
1H HRMAS NMR data of liver obtained
from control (black boxes) and infected (red dots) mice at week 5 post-infection.
doi:10.1371/journal.pntd.0000807.g005
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Such stimulated glycolysis has also been observed for mice with S.
mansoni infection for 49 days [28]. However, we further observed
significant elevation of the plasma glucose for the infected mice at
week 3 and 4 post-infection (Fig. 3a–b) and the light-infection
group at week 5 post-infection (Fig. 3d). Such observation is
broadly agreeable with the results of a previous study [49] on S.
mansoni infection that hyperglycemia was observed for mice at the
early stage. This is probably due to active manipulation and
adaptation of parasites to the host rather than consequences of
host injuries.
S. japonicum infection further led to the TCA cycle suppression
with alleviation of plasma citrate and urinary citrate, 2-
oxoglutarate and succinate which was similar to previous
observations for S. mansoni infection [28–29]. Such changes were
also consistent with the previous findings that the expression of
TCA cycle associated enzymes decreased about 5 folds after S.
mansoni infection for 8 weeks [8]. Furthermore, the urinary 2-keto-
isocaproate, 2-keto-3-methyl-valerate and 2-keto-isovalerate were
degradation products of leucine, isoleucine and valine respectively.
The elevations of these keto acids observed here indicated that S.
japonicum infection promoted ketogenesis resulting from the
degradations of the branched-chain amino acids. Such effects
appeared to be similar to the infection by another schistosome
species S. mansoni [28].
The marked reduction of lipoproteins observed in the plasma of
S. japonicum infected mice here is broadly consistent with the results
from a proteomic study [9], which has shown that S. japonicum
absorbs up to fifty host proteins. The reduction of lipoproteins can
further be explained by the ability of adult schistosomes to take up
the host phospholipids and triacylglycerols [50] to form a lipid
tegument, which accounts for about one-third of the adult
schistosomes and plays an important role in evading the host
immune systems [51]. Therefore, the observed reduction of
lipoproteins in the plasma of infected mice is probably a common
Figure 6. PLS correlation of the NMR spectral data of biofluids and liver tissues with the worm burden. PLS correlation plot derived
from the CPMG filtered
1H NMR data for plasma (R
2X=0.521, Q
2=0.281) (A),
1H HRMAS NMR data for liver tissue (R
2X=0.541, Q
2=0.501) (B) and
1H
NMR data for urine samples (R
2X=0.455, Q
2=0.305) (C), which were all obtained from infected mice at week 5 post-infection, against worm burden.
The arrows indicated increases in the severity of the infection.
doi:10.1371/journal.pntd.0000807.g006
Figure 7. Metabolite concentration changes relative to corre-
sponding controls at different time points after S. japonicum
infection. The insert showed different severity at week 5 post
infection. Keys: 3-UP, 3-ureidopropionate; PAG, phenylacetylglycine; 2-
Kiv, 2-keto-isovalerate; DMA, dimethylamine; TMA, trimethylamine. Cinf
and Ccon stand for the averaged concentration in the infection and
control group, respectively. Dashed lines indicated no changes and
solid lines were for visual guidance only.
doi:10.1371/journal.pntd.0000807.g007
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mansoni species [52] in both rodents and human [53] as well.
Moreover, the infection-induced changes of in gut microbiota
related metabolites such as PAG, hippurate, TMA and DMA
(Table 3) indicated that schistosome infection also disturbed the
gut microbial ecology. This was broadly similar to the effects of
infection by S. mansoni [28–29], suggesting such effects as a
universal consequence of schistosomiasis. Amongst the microbial
related metabolites, elevations of 4-cresol glucuronide and PAG
and depressed levels of hippurate appeared to be common for the
hosts infected with helminths [28–29] and intestinal nematodes
[54]. Further research is required to determine the fine-grained
alterations in the microbial community associated with infection,
which will enhance our understanding of three-way host-parasite-
microbiota interactions.
In this study, elevation of urinary 3-UP was found in mice
infected with S. japonicum. Such metabolite has also been found
recently in the urine samples of mice 53 days after infection by S.
mansoni with the combination of NMR and capillary electropho-
resis methods [55]. However, our detection of urinary 3-UP in
mice at the third week of S. japonicum infection was four weeks
earlier than that in the previous investigation. In addition, the
levels of 3-UP was positively correlated with disease progression
and worm burden (Fig. 7). Therefore, urinary 3-UP could be a
potential biomarker for early diagnosis of schistosome infection.
Elevated urinary 3-UP has previously been found in a case of
inborn error of b-ureidopropionase deficiency [56] and reported
to be a neuro-toxin [57]. The elevated urinary 3-UP in this study
suggested that the schistosomal infection caused reduction of b-
ureidopropionase activity thus disturbed uracil metabolism. Such
alterations are also reflected with the elevation of another uracil
metabolite, malonate, after infection for five weeks. The presence
and specificity of 3-UP is warranted for further verification as an
early diagnostic biomarker in the schistosome infected humans
and other animals.
In conclusion, metabonomic analyses of urinary and plasma
samples were effective, with little or no invasiveness, in detecting S.
japonicum infection to mice one week prior to the ‘‘gold standard’’
method and in distinguishing the severity of such infections in
terms of worm-burdens. A good correlation of elevation of the
urinary 3-UP is clearly evident with worm burden and
progression. The overall metabonomic changes in plasma, urine
and liver of infected animals were also associated with the time-
course of S. japonicum infection. Most of the metabolic responses to
S. japonicum infection were broadly similar to what previously
observed to S. mansoni infection indicating the generic metabolic
consequences of schistosomiasis. We further discovered the
alterations of pyrimidine and lipid metabolisms induced by
schistosome infection. The changed metabolites in the plasma
and liver coincided with the schistosome development and were
consistent with the metabolic signature of the early stage of liver
damage. Our findings on mechanisms of host-parasite interaction
in the disease process over time provide a new basis for
development of an early diagnosis tool. Further investigation of
metabolic alterations due to parasitic infections in humans is
necessary to evaluate the specificity of the altered metabolites in
human populations.
Supporting Information
Alternative Language Abstract S1 Translation of the abstract
into Chinese by Junfang Wu.
Found at: doi:10.1371/journal.pntd.0000807.s001 (0.03 MB
DOC)
Figure S1 Histopathological results of liver from a non-infected
mouse (A) and a mouse infected with S. japonicum for 5 weeks (B)
(200 times). The arrows on the right hand side slice showed S.
japonicum eggs.
Found at: doi:10.1371/journal.pntd.0000807.s002 (3.35 MB TIF)
Figure S2 PCA trajectory plots of plasma (A) and urine (B) data
obtained from the mean PC1 and PC2 values of the S. japonicum
infected mice (red) and its corresponding controls (blue) at
indicated time point with error bars representing the standard
deviations.
Found at: doi:10.1371/journal.pntd.0000807.s003 (0.72 MB TIF)
Figure S3 Plots of permutation tests (n=200) for plasma profiles
of controls and infected mice at pre-infection (A), at week 4 post-
infection (B), control and heavily-infected mice at week 5 post-
infection (C), and for liver profiles from control and infected mice
at week 5 post-infection (D). R
2 describes how well the derived
model fits the data; Q
2 describes the predictive ability of the
derived model. Intercept values: (A) R
2: 0.215, Q
2: 20.107; (B)
R
2: 0.255, Q
2:20.122; (C) R
2: 0.228, Q
2: 20.251; (D) R
2: 0.305,
Q
2: 20.253.
Found at: doi:10.1371/journal.pntd.0000807.s004 (0.91 MB TIF)
Figure S4 Permutation tests (n=200) for models obtained from
urinary profiles of controls and infected mice at pre-infection (A),
week 3 post-infection (B), week 4 post-infection (C) and from
control and heavily-infected mice at week 5 post-infection (D).
Intercept values are shown on each plot. Intercept values: (A) R
2:
0.355, Q
2: 20.144; (B) R
2: 0.297, Q
2: 20.249; (C) R
2: 0.277, Q
2:
20.198; (D) R
2: 0.311, Q
2: 20.253.
Found at: doi:10.1371/journal.pntd.0000807.s005 (0.17 MB TIF)
Text S1 Description of permutation test. Figures: Histopatho-
logical results of liver from a control mouse and a S. japonicum
infected mouse for 5 weeks. PCA trajectory plot of plasma and
urine spectra obtained from the S. japonicum infected mice and their
corresponding control at different time point. The results obtained
from the permutation tests for NMR data obtained from plasma at
several time points and liver. The results obtained from the
permutation tests for NMR data obtained from urine at several
time points.
Found at: doi:10.1371/journal.pntd.0000807.s006 (0.03 MB
DOC)
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